Artigos com autorizações de acesso público - Markus RiesterSaiba mais
31 artigos disponíveis publicamente
Highly Specific Gene Silencing by Artificial MicroRNAs in Arabidopsis
R Schwab, S Ossowski, M Riester, N Warthmann, D Weigel
The Plant Cell 18 (5), 1121-1133, 2006
Autorizações: German Research Foundation
Most human non-GCIMP glioblastoma subtypes evolve from a common proneural-like precursor glioma
T Ozawa, M Riester, YK Cheng, JT Huse, M Squatrito, K Helmy, N Charles, ...
Cancer cell 26 (2), 288-300, 2014
Autorizações: US National Institutes of Health
JAK–STAT pathway activation in malignant and nonmalignant cells contributes to MPN pathogenesis and therapeutic response
M Kleppe, M Kwak, P Koppikar, M Riester, M Keller, L Bastian, T Hricik, ...
Cancer discovery 5 (3), 316-331, 2015
Autorizações: US National Institutes of Health
Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer
M Riester, JM Taylor, A Feifer, T Koppie, JE Rosenberg, RJ Downey, ...
Clinical cancer research 18 (5), 1323-1333, 2012
Autorizações: US National Institutes of Health
Risk Prediction for Late-Stage Ovarian Cancer by Meta-analysis of 1525 Patient Samples
M Riester, W Wei, L Waldron, AC Culhane, L Trippa, E Oliva, S Kim, ...
Journal of the National Cancer Institute, dju048, 2014
Autorizações: US National Institutes of Health
Evolution of the cancer genome
O Podlaha, M Riester, S De, F Michor
Trends in Genetics 28 (4), 155-163, 2012
Autorizações: US National Institutes of Health
curatedOvarianData: clinically annotated data for the ovarian cancer transcriptome
BF Ganzfried, M Riester, B Haibe-Kains, T Risch, S Tyekucheva, I Jazic, ...
Database 2013, 2013
Autorizações: US National Institutes of Health
Aberration in DNA Methylation in B-Cell Lymphomas Has a Complex Origin and Increases with Disease Severity
S De, R Shaknovich, M Riester, O Elemento, H Geng, M Kormaksson, ...
PLoS genetics 9 (1), e1003137, 2013
Autorizações: US National Institutes of Health
Tracking the evolution of resistance to ALK tyrosine kinase inhibitors through longitudinal analysis of circulating tumor DNA
I Dagogo-Jack, AR Brannon, LA Ferris, CD Campbell, JJ Lin, KR Schultz, ...
JCO precision oncology 2, 1-14, 2018
Autorizações: US National Institutes of Health
Comparative meta-analysis of prognostic gene signatures for late-stage ovarian cancer
L Waldron, B Haibe-Kains, AC Culhane, M Riester, J Ding, XV Wang, ...
Journal of the National Cancer Institute 106 (5), dju049, 2014
Autorizações: US National Institutes of Health
Cross-study validation for the assessment of prediction algorithms
C Bernau, M Riester, AL Boulesteix, G Parmigiani, C Huttenhower, ...
Bioinformatics 30 (12), i105-i112, 2014
Autorizações: US National Institutes of Health, German Research Foundation
Software for the integration of multiomics experiments in bioconductor
M Ramos, L Schiffer, A Re, R Azhar, A Basunia, C Rodriguez, T Chan, ...
Cancer research 77 (21), e39-e42, 2017
Autorizações: US National Science Foundation, US National Institutes of Health
Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features
JJ Pitt, M Riester, Y Zheng, TF Yoshimatsu, A Sanni, O Oluwasola, ...
Nature communications 9 (1), 4181, 2018
Autorizações: US National Institutes of Health, Versus Arthritis, UK, Cancer Research UK …
Multiomic analysis of subtype evolution and heterogeneity in high-grade serous ovarian carcinoma
L Geistlinger, S Oh, M Ramos, L Schiffer, RS LaRue, CM Henzler, ...
Cancer research 80 (20), 4335-4345, 2020
Autorizações: US National Institutes of Health, German Research Foundation
Integrative analysis of 1q23. 3 copy-number gain in metastatic urothelial carcinoma
M Riester, L Werner, J Bellmunt, S Selvarajah, EA Guancial, BA Weir, ...
Clinical Cancer Research 20 (7), 1873-1883, 2014
Autorizações: US National Institutes of Health, Government of Spain
The Warburg effect: persistence of stem-cell metabolism in cancers as a failure of differentiation
M Riester, Q Xu, A Moreira, J Zheng, F Michor, RJ Downey
Annals of Oncology 29 (1), 264-270, 2018
Autorizações: US National Institutes of Health
HER2 as a target in invasive urothelial carcinoma
J Bellmunt, L Werner, A Bamias, AP Fay, RS Park, M Riester, ...
Cancer medicine 4 (6), 844-852, 2015
Autorizações: US National Institutes of Health, Government of Spain
Bisulfite-independent analysis of CpG island methylation enables genome-scale stratification of single cells
L Han, HJ Wu, H Zhu, KY Kim, SL Marjani, M Riester, G Euskirchen, X Zi, ...
Nucleic acids research 45 (10), e77-e77, 2017
Autorizações: US National Institutes of Health
A differentiation-based phylogeny of cancer subtypes
M Riester, C Stephan-Otto Attolini, RJ Downey, S Singer, F Michor
PLoS computational biology 6 (5), e1000777, 2010
Autorizações: US National Institutes of Health
An evolutionary approach for identifying driver mutations in colorectal cancer
J Foo, LL Liu, K Leder, M Riester, Y Iwasa, C Lengauer, F Michor
PLoS computational biology 11 (9), e1004350, 2015
Autorizações: US National Institutes of Health
As informações de publicação e financiamento são determinadas automaticamente por um programa de computador